The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effect of age on first-line sunitinib treatment in patients with renal cell carcinoma (RCC).
J. I. G. Coward
No relevant relationships to disclose
E. D. Larbi
No relevant relationships to disclose
H. S. Pandha
No relevant relationships to disclose
A. Michael
No relevant relationships to disclose